0000921895-24-001362.txt : 20240607
0000921895-24-001362.hdr.sgml : 20240607
20240607160224
ACCESSION NUMBER: 0000921895-24-001362
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240606
FILED AS OF DATE: 20240607
DATE AS OF CHANGE: 20240607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Green James W
CENTRAL INDEX KEY: 0001400121
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33957
FILM NUMBER: 241029187
MAIL ADDRESS:
STREET 1: 12525 CHADRON AVENUE
CITY: HAWTHORNE
STATE: CA
ZIP: 90250
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HARVARD BIOSCIENCE INC
CENTRAL INDEX KEY: 0001123494
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 043306140
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 84 OCTOBER HILL RD
CITY: HOLLISTON
STATE: MA
ZIP: 01746
BUSINESS PHONE: 5088938999
MAIL ADDRESS:
STREET 1: 84 OCTOBER HILL ROAD
CITY: HOLLISTON
STATE: MA
ZIP: 01746
4
1
form412799001_06072024.xml
OWNERSHIP DOCUMENT
X0508
4
2024-06-06
0
0001123494
HARVARD BIOSCIENCE INC
HBIO
0001400121
Green James W
C/O HARVARD BIOSCIENCE, INC.
84 OCTOBER HILL ROAD
HOLLISTON
MA
01746
1
1
0
0
Chief Executive Officer
0
Common Stock
2024-06-06
4
P
0
20000
3.07
A
3101091
D
This transaction was executed in multiple trades at prices ranging from $3.03 to $3.12, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes (a) 235,427 RSUs that will vest in two equal installments on December 29, 2024 and 2025, (b) 52,346 RSUs that will vest on December 29, 2024, (c) 214,797 RSUs that will vest in three equal installments on March 19, 2025, 2026 and 2027, (d) 699,772 RSUs with performance based vesting conditions and (e) 1,898,749 shares of common stock beneficially owned by the Reporting Person.
/s/ David Sirois, by power of attorney
2024-06-07